In addition, Metzger et al. [102] observed an overall improvement on letter and category fluency tasks, as well as on PFC and speech areas activation that supported the positive neurobiological effects of cholinesterase inhibition on cognitive functions in AD patients. Here, BCHE is linked to Alzheimer disease.